2015
Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials
Scahill L, Sukhodolsky DG, Anderberg E, Dimitropoulos A, Dziura J, Aman MG, McCracken J, Tierney E, Hallett V, Katz K, Vitiello B, McDougle C. Sensitivity of the modified Children’s Yale–Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials. Autism 2015, 20: 145-152. PMID: 25882391, DOI: 10.1177/1362361315574889.Peer-Reviewed Original Research
2014
Examination of Aggression and Self-injury in Children with Autism Spectrum Disorders and Serious Behavioral Problems
Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L. Examination of Aggression and Self-injury in Children with Autism Spectrum Disorders and Serious Behavioral Problems. Child And Adolescent Psychiatric Clinics Of North America 2014, 23: 57-72. PMID: 24231167, PMCID: PMC4212264, DOI: 10.1016/j.chc.2013.08.002.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAggressionAnalysis of VarianceAntipsychotic AgentsChildChild Development Disorders, PervasiveChild, PreschoolChi-Square DistributionDouble-Blind MethodFemaleHumansIntelligence TestsMaleOutcome Assessment, Health CarePsychiatric Status Rating ScalesRandomized Controlled Trials as TopicRisperidoneSelf-Injurious BehaviorSeverity of Illness IndexConceptsAutism spectrum disorderSubtypes of aggressionSelf-injurious behaviorSpectrum disorderUnderstanding of aggressionSerious behavioral problemsParent interviewsBehavioral problemsSelf-InjuryAggressionStudy findingsChildrenRisperidone trialsChildren 2DisordersIndividualized treatmentPositive responseSubtypesFurther studiesBiological mechanismsHigh rateInterviewsFindingsNarrativesBehavior
2013
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
Nurmi E, Spilman S, Whelan F, Scahill L, Aman M, McDougle C, Arnold L, Handen B, Johnson C, Sukhodolsky D, Posey D, Lecavalier L, Stigler K, Ritz L, Tierney E, Vitiello B, McCracken J. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Translational Psychiatry 2013, 3: e274-e274. PMID: 23799528, PMCID: PMC3693401, DOI: 10.1038/tp.2013.26.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAlpha-Ketoglutarate-Dependent Dioxygenase FTOAmidohydrolasesAntipsychotic AgentsBody WeightChildChild Development Disorders, PervasiveChild, PreschoolFemaleGenetic Predisposition to DiseaseHumansLeptinMaleProteinsReceptor, Cannabinoid, CB1Receptor, Melanocortin, Type 4RisperidoneWeight GainConceptsWeight gainAntipsychotic-associated weight gainAntipsychotic-induced weight gainEndocannabinoid metabolic enzymesPrior adult studiesTreatment-naive populationExcessive weight gainHigh-risk groupFatty acid amide hydrolaseTreatment of irritabilityChildren/adolescentsRisperidone studyAntipsychotic exposureAdverse eventsPlasma levelsRisk groupsAdult studiesCannabinoid receptorsNetwork trialAmide hydrolasePharmacogenetic basisGene variantsSignificant riskTrend associationNaive population
2011
Effects of Risperidone and Parent Training on Adaptive Functioning in Children With Pervasive Developmental Disorders and Serious Behavioral Problems
Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, Hollway JA, Korzekwa P, Gavaletz A, Kohn AE, Koenig K, Grinnon S, Mulick JA, Yu S, Vitiello B, Network R. Effects of Risperidone and Parent Training on Adaptive Functioning in Children With Pervasive Developmental Disorders and Serious Behavioral Problems. Journal Of The American Academy Of Child & Adolescent Psychiatry 2011, 51: 136-146. PMID: 22265360, PMCID: PMC3941712, DOI: 10.1016/j.jaac.2011.11.010.Peer-Reviewed Original ResearchAdaptation, PsychologicalAdolescentAntipsychotic AgentsAsperger SyndromeAutistic DisorderChecklistChildChild Behavior DisordersChild Development Disorders, PervasiveChild, PreschoolCombined Modality TherapyCommunicationCooperative BehaviorDose-Response Relationship, DrugEducationFemaleHumansMaleRisperidoneSocialization
2009
Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial
Aman MG, Mcdougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A, Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A, Network F. Medication and Parent Training in Children With Pervasive Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical Trial. Journal Of The American Academy Of Child & Adolescent Psychiatry 2009, 48: 1143-1154. PMID: 19858761, PMCID: PMC3142923, DOI: 10.1097/chi.0b013e3181bfd669.Peer-Reviewed Original ResearchConceptsPervasive developmental disorderClinical trialsClinical Global Impressions-Improvement scoreAberrant Behavior Checklist IrritabilityParallel-group clinical trialParent trainingBehavioral problemsDevelopmental disordersRisperidone doseRisperidone monotherapyHyperactivity/noncompliance subscaleSevere behavioral problemsCOMB groupPT sessionsQuestionnaire scoresHSQ scoresMedicationsGreater reductionChildrenPrimary measureRisperidoneSignificant reductionStereotypic behaviorScoresDose
2007
Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning
Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B. Parent-Rated Anxiety Symptoms in Children with Pervasive Developmental Disorders: Frequency and Association with Core Autism Symptoms and Cognitive Functioning. Research On Child And Adolescent Psychopathology 2007, 36: 117-128. PMID: 17674186, DOI: 10.1007/s10802-007-9165-9.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAggressionAntipsychotic AgentsAnxietyAsperger SyndromeAttention Deficit Disorder with HyperactivityAutistic DisorderCentral Nervous System StimulantsChildChild Development Disorders, PervasiveChild, PreschoolCognition DisordersComorbidityCross-Over StudiesDouble-Blind MethodFemaleHumansIntelligenceLanguage Development DisordersMaleMethylphenidatePersonality AssessmentRandomized Controlled Trials as TopicRisperidoneSocial BehaviorStereotyped BehaviorConceptsPervasive developmental disorderParent-rated anxiety symptomsAnxiety symptomsHigher IQCore symptomsDevelopmental disordersCore autism symptomsAdolescent Symptom InventoryFunctional language useMedication-free childrenSocial anxietyAutism symptomsCognitive functioningParent ratingsSocial reciprocityResultsForty-three percentProblem behaviorAnxiety disordersSymptom InventoryOverall impairmentAnxietyGreater impairmentLanguage useStereotyped behaviorIQ